Angiotensin Converting Enzyme Inhibitor

<strong>Angiotensin Converting Enzyme Inhibitor</strong>_x000D_ <strong>Catalog number:</strong> B2010519_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 1101.26 g/mol_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> molecular tool for various ACE-related research studies_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> ACE Inhibitor_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Brown T, Gonzalez J, Monteleone C. Angiotensin-converting enzyme inhibitor-_x000D_ induced angioedema: A review of the literature. J Clin Hypertens (Greenwich)._x000D_ 2017 Dec;19(12):1377-1382._x000D_ _x000D_ 2: Dicpinigaitis PV. Angiotensin-converting enzyme inhibitor-induced cough: ACCP_x000D_ evidence-based clinical practice guidelines. Chest. 2006 Jan;129(1_x000D_ Suppl):169S-173S._x000D_ _x000D_ 3: Bankston J, House DT. Angiotensin-Converting_Enzyme_Inhibitor Angioedema. Adv_x000D_ Emerg Nurs J. 2020 Apr/Jun;42(2):103-107._x000D_ _x000D_ 4: De Bono JA, Conte SM, Newcomb AE. Effects of Preoperative Angiotensin-_x000D_ Converting Enzyme_Inhibitor Therapy on Postoperative Renal Function in Cardiac_x000D_ Surgery. Heart Lung Circ. 2020 Nov;29(11):1656-1667._x000D_ _x000D_ 5: Xu J, Teng Y, Shang L, Gu X, Fan G, Chen Y, Tian R, Zhang S, Cao B. The_x000D_ Effect of Prior Angiotensin-Converting Enzyme_Inhibitor and Angiotensin Receptor_x000D_ Blocker Treatment on Coronavirus Disease 2019 (COVID-19) Susceptibility and_x000D_ Outcome: A Systematic Review and Meta-analysis. Clin Infect Dis. 2021 Jun_x000D_ 1;72(11):e901-e913._x000D_ _x000D_ 6: Laurent S. Antihypertensive drugs. Pharmacol Res. 2017 Oct;124:116-125._x000D_ _x000D_ 7: Sobotková M. Angiotensin-converting_enzyme_inhibitor-induced angioedema:_x000D_ epidemiology, pathogenesis and management. Vnitr Lek. 2018 Fall;64(10):928-933._x000D_ English._x000D_ _x000D_ 8: de Feria A, Ortega-Legaspi JM. Angiotensin-converting_Enzyme_x000D_ Inhibitor/Angiotensin Receptor Blocker Use and COVID-19: Time to Change Practice_x000D_ or Keep Gathering Data? Clin Infect Dis. 2020 Dec 3;71(9):2457-2458._x000D_ _x000D_ 9: Sommerstein R, Kochen MM, Messerli FH, Gräni C. Coronavirus Disease 2019_x000D_ (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor_x000D_ Blockers Have a Biphasic Effect? J Am Heart Assoc. 2020 Apr 7;9(7):e016509._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/21896148/">10: Izzo JL Jr, Weir MR. Angiotensin-converting enzyme inhibitors. J Clin_x000D_ Hypertens (Greenwich). 2011 Sep;13(9):667-75.</a>_x000D_ _x000D_ <strong>Products Related to Angiotensin Converting Enzyme Inhibitor and other chemicals</strong> <a href="https://moleculardepot.com/product-category/SARS-CoV-2/">: SARS-CoV-2</a>